Certara is the leading drug development consultancy with solutions spanning the discovery, preclinical and clinical stages of drug development.
PRINCETON, NJ – February 21, 2019 – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19.1 of its flagship scientific informatics platform D360.
Read MoreSelf-service informatics platform for data design, access, and analysis for small molecules and biologics.
Read MoreAugust 16, 2018 – Certara today announced the launch of D360 v10.5, the first in a series of releases focused on delivering biologic-relevant tools together with D360’s data access capabilities.
Read MoreDavid Lowis described a case study where D360 was used to replace older technologies at a biotechnology company. He also showed D360’s new visualization tools and shares the future roadmap as D360 advances its support of biologics in addition to small molecules.
Read MorePRINCETON, NJ – Feb. 14, 2018 – Certara today announced the launch of version 10 of D360, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution used to query diverse cheminformatics and bioinformatics data sources to make informed go/no go research decisions.
Read MoreD360 Partner is an affordable add-on product for D360 for external partners that allows for seamless, secure sharing of data and analysis while advancing communication and collaboration.
Read MoreD360 Express is an out-of-the-box integrated solution specifically designed for discovery scientists at smaller pharmaceutical research organizations. It provides access, integration, analysis and visualization of scientific data from multiple data sources. D360 Express gets you up and running quickly and affordably.
Read MoreScientific Data Informatics Hub for Discovery Research Small molecule drug discovery research requires the ability to access and understand biological, chemical, logistical, and computational data from a wide variety of sources. A major challenge for scientists is the significant time and resources needed to find and access this data quickly and efficiently in order to make […]
Read MoreD360 removes the major roadblocks that preclinical scientists encounter when answering questions related to safety data by making the data easily available, in a format that is readily accessible and usable. As a result, answers are arrived at quickly and easily, and scientists are enabled to ask questions that were previously impossible to ask.
Read MoreD360 brings together data from different sources and provides integrated analysis and collaboration tools to support a wide variety of workflows across scientific disciplines.
Read MoreDiscovery drug research requires understanding complex biological, chemical, logistical and computational data from a wide variety of data sources. Certara’s D360 platform was specifically designed to meet the discovery researcher’s workflow needs.
Read MorePRINCETON, NJ – June 23, 2016 – The D360 packaged informatics solution reduces research cycle time, delivering faster insights for busy discovery scientists.
Read MoreProviding scientists with access to project data and tools to analyze and collaborate is vitally important to improving the effectiveness of rational, data-driven research. This capability must be provided without undue burden or cost on already stretched IT resources. D360™ is a scientific informatics tool that meets these criteria.
Read MoreA global top-10 pharma company engaged in an initiative using Certara’s D360 to better address cross-study analysis of pre-clinical safety data.
Read MoreA small biotech company used Certara’s D360 to better address access and analysis of chemical and biological data by its scientists.
Read MoreA top-40 pharma company enhanced data access and decision support for pre-clinical safety with Certara’s D360 and a specialized CDISC SEND-based database.
Read MoreA discovery team lowers IT costs and improves end-user functionality by standardizing on Certara’s D360 drug discovery platform.
Read MoreMedivir sees a fast return on its investment—time savings and enhanced informativeness of data activities—using Certara’s D360.
Read MoreData Informatics Platform for Discovery Scientists Drug discovery research requires understanding complex chemical, biological, logistical, and computational data from a wide variety of data sources. A key challenge for discovery scientists is the ability to efficiently access the most current and relevant data from internal and external data sources, ideally in a consolidated and cohesive project […]
Read MoreCertara’s Informatics Platform Facilitates Scientific Data Access, Analysis, and Collaboration within an Organization and Amongst Development Partners D360 Data Informatics Platform for Discovery Scientists D360™ is the industry-leading scientific data informatics hub used globally by over 5,000 discovery research scientists. It was designed to meet the discovery researcher’s workflow needs by providing a self-service data […]
Read More